{"id":"https://openalex.org/W2099190385","doi":"https://doi.org/10.1001/archpsyc.1995.03950240089014","title":"Conversions From Clozapine to Other Antipsychotic Drugs","display_name":"Conversions From Clozapine to Other Antipsychotic Drugs","alternate_titles":[],"publication_year":1995,"publication_date":"1995-12-01","ids":{"openalex":"https://openalex.org/W2099190385","doi":"https://doi.org/10.1001/archpsyc.1995.03950240089014","mag":"2099190385","pmid":"https://pubmed.ncbi.nlm.nih.gov/7492259"},"language":"en","primary_location":{"id":"doi:10.1001/archpsyc.1995.03950240089014","doi":"https://doi.org/10.1001/archpsyc.1995.03950240089014","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.1995.03950240089014","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2099190385"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084589130","display_name":"David Martin Gardner","orcid":"https://orcid.org/0000-0002-0980-6399","observed_orcids":["https://orcid.org/0000-0002-0980-6399"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David M. Gardner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5084589130"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6456,"has_fulltext":false,"cited_by_count":32,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88474913,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"52","issue":"12","first_page":"1071","last_page":"1071"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12666","display_name":"Historical Psychiatry and Medical Practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.7129999995231628},{"id":"https://openalex.org/keywords/clozapine-withdrawal","display_name":"clozapine withdrawal","score":0.7680000066757202},{"id":"https://openalex.org/keywords/antipsychotic-potency","display_name":"antipsychotic potency","score":0.7480000257492065},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8529999852180481},{"id":"https://openalex.org/keywords/psychotic-symptoms","display_name":"psychotic symptoms","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.9029046297073364},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7950804233551025},{"id":"https://openalex.org/C2910202354","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic Agent","level":4,"score":0.6247597932815552},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.6163715124130249},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.5836032032966614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4568087160587311},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.367371141910553},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36533039808273315},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33285847306251526},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1823175549507141},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/archpsyc.1995.03950240089014","doi":"https://doi.org/10.1001/archpsyc.1995.03950240089014","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.1995.03950240089014","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},{"id":"pmid:7492259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7492259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of general psychiatry","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2032541343","display_name":"SYNAPTIC TRANSMISSION IN THE CENTRAL NERVOUS SYSTEMS","funder_award_id":"K05MH047370","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G5659475510","display_name":"BIOLOGICAL RESEARCH IN SCHIZOPHRENIA","funder_award_id":"P01MH031154","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G5875104833","display_name":null,"funder_award_id":"MH47370","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W153750880","https://openalex.org/W1666860950","https://openalex.org/W1964422144","https://openalex.org/W1969486640","https://openalex.org/W1983341781","https://openalex.org/W2007589067","https://openalex.org/W2032819792","https://openalex.org/W2045581755","https://openalex.org/W2054505604","https://openalex.org/W2059230444","https://openalex.org/W2060108853","https://openalex.org/W2062097228","https://openalex.org/W2079725667","https://openalex.org/W2145478036","https://openalex.org/W2151266799","https://openalex.org/W2243263130","https://openalex.org/W2286137270","https://openalex.org/W2396393259","https://openalex.org/W2412413921","https://openalex.org/W2418757997","https://openalex.org/W2435724631","https://openalex.org/W3027134881"],"related_works":["https://openalex.org/W2986685354","https://openalex.org/W2332073462","https://openalex.org/W2031952693","https://openalex.org/W1995585472","https://openalex.org/W7064835291","https://openalex.org/W7160402450","https://openalex.org/W4211103382","https://openalex.org/W2167217303","https://openalex.org/W1990712459","https://openalex.org/W2039977584"],"abstract_inverted_index":{"Conversions":[0,35],"between":[1,36],"dissimilar":[2],"antipsychotic":[3,42],"agents":[4,22],"can":[5],"be":[6],"problematic.":[7],"Agents":[8],"of":[9,14,23,30,62,64],"low":[10],"potency":[11,25],"present":[12],"risks":[13],"central":[15],"depressant":[16],"and":[17,38,51,90,103,138],"autonomic":[18],"side":[19],"effects,":[20],"whereas":[21],"high":[24],"carry":[26],"a":[27,59,122],"higher":[28],"risk":[29,120],"inducing":[31],"acute":[32],"extrapyramidal":[33],"effects.":[34],"clozapine":[37,71],"other":[39],"more":[40,107],"typical":[41],"drugs,":[43],"including":[44],"the":[45],"new":[46],"agent":[47],"risperidone,1are":[48],"increasingly":[49],"common":[50],"may":[52],"cause":[53],"special":[54],"problems.":[55],"For":[56],"example,":[57],"over":[58,100,121],"dozen":[60],"cases":[61,81,130],"worsening":[63],"psychotic":[65],"symptoms":[66],"after":[67,111],"abrupt":[68],"withdrawal":[69],"from":[70],"therapy":[72],"have":[73,82],"been":[74,83],"reported2-7and":[75],"at":[76,86,132],"least":[77],"five":[78],"additional":[79],"similar":[80],"observed":[84,131],"recently":[85],"our":[87,133],"centers":[88,134],"(D.M.G":[89],"R.J.B.,":[91],"unpublished":[92],"data,":[93],"June":[94],"1995).":[95],"These":[96],"reactions":[97],"often":[98],"evolved":[99],"several":[101,127],"days":[102],"so":[104],"were":[105],"much":[106],"rapid":[108],"than":[109],"relapses":[110],"stopping":[112],"treatment":[113],"with":[114],"standard":[115],"agents,":[116],"which":[117],"average":[118],"50%":[119],"3-":[123],"to":[124],"4-month":[125],"period.8,9Moreover,":[126],"case":[128],"reports6,10,11and":[129],"(by":[135],"D.M.G.,":[136],"D.L.G.,":[137],"R.J.B.":[139],"May":[140],"1995)":[141]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2099190385","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
